Skin cancer kills by spreading from the skin to vital organs, where growing tumors disrupt normal function until those organs fail. The skin tumor itself is almost never the direct cause of death. Instead, cancer cells break away from the original site, travel through the lymphatic system or bloodstream, and establish new tumors in the brain, lungs, liver, bones, or other critical areas. This process, called metastasis, is what transforms a treatable surface-level cancer into a life-threatening disease.
How quickly and aggressively this happens depends heavily on the type of skin cancer. Melanoma is the most dangerous, but squamous cell carcinoma and even basal cell carcinoma can be fatal under certain circumstances.
How Cancer Cells Travel From Skin to Organs
Cancer cells face significant obstacles when trying to spread. Melanoma cells circulating in the bloodstream experience intense oxidative stress, a chemical imbalance that damages the outer membrane of the cell and typically kills it. Research from the National Cancer Institute found that melanoma cells are particularly vulnerable to a form of cell death where damaged fats accumulate in their outer membrane, causing it to become leaky and eventually collapse.
But melanoma cells have found a workaround. Before entering the blood, they often stop in nearby lymph nodes first. While there, the cells absorb high levels of a protective fatty acid called oleic acid, which gets incorporated into their outer membranes. This essentially coats them in armor. The oleic acid replaces the damaged fats that would otherwise kill the cell, making it resistant to the oxidative stress it will face in the bloodstream. Once fortified, the cells enter the blood and survive long enough to reach distant organs and begin growing there.
This is why swollen lymph nodes near a skin cancer site are such an important warning sign. They often represent a staging ground where cancer cells are preparing to spread further.
Where Metastatic Skin Cancer Spreads
Melanoma most commonly spreads to the lungs, liver, brain, bones, and small bowel. Each location produces its own cascade of problems as tumors grow and crowd out healthy tissue.
Brain. Tumors in the brain can cause memory problems, personality changes, seizures, confusion, severe headaches, and progressive weakness in the arms or legs. Brain metastases are among the most dangerous because even small tumors can disrupt critical functions, and the skull leaves no room for swelling.
Lungs. Cancer in the lungs causes a persistent cough, breathlessness, coughing up blood, and fluid buildup between the chest wall and lung. As tumors replace functional lung tissue, the body’s ability to absorb oxygen steadily declines.
Liver. The liver filters blood and produces essential proteins. Tumors there cause pain on the right side of the abdomen, jaundice (yellowing of the skin), fluid buildup in the abdomen, poor appetite, and severe weight loss. Eventually the liver can no longer perform its filtering and metabolic functions.
Bones. Cancer in the bones causes continuous, gnawing pain and weakens the bone structure, making fractures more likely. It also raises blood calcium levels, which leads to dehydration, confusion, nausea, and constipation. When cancer invades the spinal bones, it can compress the spinal cord and cause paralysis, numbness, and loss of bladder and bowel control. Bone marrow infiltration reduces blood cell production, leading to anemia, increased infection risk, and uncontrolled bleeding.
Small bowel. Tumors here cause abdominal pain, nausea, weight loss, and anemia. They can partially or fully block the intestine, preventing food from passing through and causing severe cramping pain.
How the Body Breaks Down
Death from metastatic skin cancer rarely comes from a single tumor in a single organ. It’s typically the cumulative failure of multiple systems. Tumors in the lungs reduce oxygen delivery. Tumors in the liver impair the body’s ability to process toxins and nutrients. Tumors in the bones reduce blood cell production. Together, these failures compound each other.
The body also wages an immune and metabolic war against widespread cancer that is itself destructive. Tumors produce hormones, cytokines, and other bioactive substances that create systemic effects unrelated to where the tumors are physically located. These are called paraneoplastic syndromes. In melanoma, they can include persistent unexplained fevers and a condition called cutaneous melanosis, where melanin overproduction turns the skin grayish. Melanosis typically signals an extremely high tumor burden, and life expectancy at that point ranges from weeks to a few months.
Advanced cancer also drives severe weight loss and muscle wasting, a condition called cachexia. The body’s metabolism shifts dramatically as tumors consume energy and trigger inflammatory responses that break down muscle and fat stores. This progressive weakening makes the body increasingly unable to tolerate the stress of organ dysfunction.
How Each Type of Skin Cancer Kills Differently
Melanoma
Melanoma is responsible for the vast majority of skin cancer deaths. It grows quickly, metastasizes early, and can spread to virtually any organ. The five-year survival rate for melanoma that has spread to distant parts of the body is 35%, based on patients diagnosed between 2015 and 2021. That number has improved in recent years. Deaths from metastatic melanoma among white Americans dropped roughly 18% between 2013 and 2016, driven largely by new immunotherapy and targeted therapy treatments. But distant melanoma remains dangerous, and the brain is a particularly common and deadly destination.
Squamous Cell Carcinoma
Squamous cell carcinoma kills differently than melanoma. A study tracking 1,400 patients found that most who died from this cancer did not die from tumors spreading to distant organs. Instead, they died from the tumor invading directly into nearby structures. Of 33 cancer-specific deaths in the study, 11 resulted from the tumor growing through the skull into the brain’s protective lining, blood vessels, or brain tissue itself. Another 12 died from cancer spreading to regional lymph nodes and then growing into deeper local structures.
The biggest risk factors for dying from squamous cell carcinoma were bone invasion, which carried a tenfold increased risk of death, and a specific aggressive growth pattern called desmoplasia, which quadrupled the risk. Immunosuppression, whether from organ transplant medications or other causes, roughly tripled the risk across all modes of death. Squamous cell cancers with nerve invasion are especially dangerous: high-risk nerve involvement is associated with a nearly eightfold higher risk of death and dramatically reduced five-year survival (about 10% versus 23% without high-risk nerve involvement).
Basal Cell Carcinoma
Basal cell carcinoma is the least deadly form, and metastasis is genuinely rare. This cancer grows slowly and tends to destroy tissue locally rather than spread. Deaths typically occur only when tumors are neglected for years and grow to extreme sizes. Tumors larger than 10 cm carry about a 50% increased risk of metastasis. When basal cell carcinoma does spread to distant sites, median survival drops to about 24 months, compared to roughly seven years for cancer that has only spread regionally. But for the vast majority of patients, this cancer never reaches that point.
Why Early Detection Changes Everything
The core reason skin cancer kills is that cells gain access to the bloodstream or lymphatic system and establish themselves in organs where they can’t be easily removed. Every stage of that process takes time. A melanoma confined to the outer layer of skin has a near-perfect survival rate. Once it penetrates deeper and reaches lymph nodes, survival drops. Once it reaches distant organs, the five-year survival rate falls to 35%.
The same pattern holds for squamous cell carcinoma. A small, well-defined tumor on the skin surface is almost always curable with surgery. A tumor that has invaded bone or wrapped around nerves in the skull has become a fundamentally different disease. The biology hasn’t changed, but the geography has, and that geography is what determines whether skin cancer remains a minor procedure or a fatal diagnosis.